Diel, Ingo J. http://orcid.org/0000-0001-5717-1909
Greil, Richard
Janssen, Jan
Kluike, Christian W.
Behera, Bagmeet
Abbasi, Ali
Seesaghur, Anouchka
Kellner, Michael
Jaeger, Christine
Bjorklof, Katja
Tomova, Antoaneta
Haslbauer, Ferdinand
Funding for this research was provided by:
Amgen (Europe) GmbH
Article History
Received: 4 April 2022
Accepted: 15 August 2022
First Online: 6 September 2022
Declarations
:
: The original study protocols and informed consent forms were approved by an investigational review board, independent ethics committee, or relevant country-specific authorities and conducted in accordance with the principles of the Declaration of Helsinki.
: Written informed consent was provided by all patients before recruitment in the original studies or any data collection.
: N/A
: IJD has received consulting fees for participation in advisory boards and has given several presentations at speaker bureaus for Amgen. RG has received honoraria from AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Celgene, Daiichi Sankyo, Gilead, Merck, MSD, Novartis, Roche, Sandoz, and Takeda; has participated in consulting or an advisory role for AbbVie, AstraZeneca, Bristol Myers Squibb, Celgene, Daiichi Sankyo, Gilead, Janssen, Merck, MSD, Novartis, Roche, and Takeda; has received research funding from Amgen, AstraZeneca, Bristol Myers Squibb, Celgene, Gilead, Merck, MSD, Novartis, Roche, Sandoz, and Takeda; and has received travel, accommodations and expenses from AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Celgene Daiichi Sankyo, Gilead, Janssen, MSD, Novartis, and Roche. JJ has received consulting fees from AbbVie, Baxter, Bayer, Biotest, Bristol Myers Squibb, Celgene, Eli Lilly, Ipsen and Servier, Janssen-Cilag Ltd, Kedrion Biopharma, Merck Serono, Novartis, Octapharma, Pfizer, Pharma Mar, Puma Biotechnology, Roche, Sanofi, and Teva Pharmaceutical. CWK has participated in advisory boards for Amgen. BB is an employee of and holds stock options in Amgen. AA reports contract work with Amgen. AS is an employee of and holds stock options in Amgen. MK is a former employee of and holds stock options in Amgen. CJ is an employee of and holds stock options in Amgen. KB is a former employee of and holds stock options in Amgen. AT has no potential conflicts of interest to report. FH has participated in advisory boards for Amgen.